Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
ORI Capital
AddedFeb 13, 2024
UpdatedJun 28, 2026
ORI Capital

ORI Capital

Operating

ORI Capital: A global venture capital firm specializing in healthcare investments since 2015.

Location
Wanchai, Wan Chai, HK
Founded
2015
Firm
Compare
Portfolio
Employees
Website

ORI Capital is a venture capital firm established in 2015, specializing in early-stage investments within the healthcare sector globally. The firm focuses on innovative biotech companies, particularly in diagnostics, drug delivery, and therapeutics targeting high-mortality diseases such as cancer, cardiovascular, and neurodegenerative conditions. ORI Capital typically invests in Series A and Series B rounds.

Notable portfolio companies include AffyImmune Therapeutics, Arterys, and Enable Injections, with significant funding raised across these ventures. The firm was founded by Simone Song, who brings extensive expertise and leadership to the team. ORI Capital's investment philosophy emphasizes supporting groundbreaking healthcare innovations with the potential to address critical medical needs. The firm also offers strategic guidance and industry connections to help portfolio companies achieve their growth objectives.

ORI Capital - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments4
Current Portfolio Count2
Total Portfolio Exits1

Top Investment Stages

Series A2 (50.0%)
Series B2 (50.0%)

Stage Mix

Series A 50%Series B 50%

Concentration shown as share of disclosed investments by stage.

Recent Investments

AffyImmune Therapeutics logo

AffyImmune Therapeutics

Enable Injections logo

Enable Injections

Arterys logo

Arterys

ORI Capital - Similar Investment Firms

Oryx Ventures logo

Oryx Ventures

oryxventures.com

Orillion logo

Orillion

orillion.co

OrbiMed Advisors logo

OrbiMed Advisors

orbimed.com

Oriza Ventures logo

Oriza Ventures

orizaventures.com

Oryzn Capital logo

Oryzn Capital

Orix Growth Capital logo

Orix Growth Capital

orix.com

Origin Capital logo

Origin Capital

Orios Venture Partners logo

Orios Venture Partners

oriosvp.com

Ore Ventures logo

Ore Ventures

Original Capital logo

Original Capital

Originate Ventures logo

Originate Ventures

Orix Venture Finance logo

Orix Venture Finance

Orion Healthcare Equity Partners logo

Orion Healthcare Equity Partners

orhep.com

Syno Capital logo

Syno Capital

synocapital.com

Origami Capital Partners logo

Origami Capital Partners

origamicapital.com

ORI Capital - Classification

Also Known As
  • ORI Capital Limited
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end